149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches

149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches

Bibliographic Details
Main Authors:	Manish Jain, Jessica Flechtner, Pranay Khare, Harshal Zope, James Perry, Victoria DeVault, Mercay Reuter, Adrienne Li, Daniel DeOliveira, Hubert Lam
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Genetic algorithm based optimization of advanced solar cell designs modeled in Silvaco AtlasTM
by: Utsler, James
Published: (2012)

413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
by: Thomas Davis, et al.
Published: (2020-11-01)

Spiritan News 011
by: Holy Ghost Fathers

390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors
by: Thomas Davis, et al.
Published: (2020-11-01)

Regulation Of Natural Killer T Cell Subset Development And Function By Slam Family Receptors
by: DeVault, Victoria
Published: (2019)

Is 'Not-Trading' Informative? Evidence from Corporate Insiders' Portfolios
by: DeVault, Luke
Published: (2016)

Children at risk for reading failure in rural settings: the effectiveness of kindergarten diagnostics for prediction of reading skills
by: DeVault, Rebecca S.
Published: (2006)

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
by: Joost H van den Berg, et al.
Published: (2020-07-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Determinants for Neoantigen Identification
by: Andrea Garcia-Garijo, et al.
Published: (2019-06-01)

MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

Cancer neoantigen: Boosting immunotherapy
by: Peijia Xu, et al.
Published: (2020-11-01)

The Neoantigen Landscape of Mycosis Fungoides
by: Arunima Sivanand, et al.
Published: (2020-11-01)

Main Strategies for the Identification of Neoantigens
by: Alexander V. Gopanenko, et al.
Published: (2020-10-01)

The Role of Neoantigens in Cancer Immunotherapy
by: Yueting Zhu, et al.
Published: (2021-08-01)

Working for the environment: Pathways to environmental careers
by: DeVault, Carol Aline
Published: (2001)

An Exploration Of Gender-Specific Instructional Practices In A Single-Sex High School
by: DeVault, John Fredrick
Published: (2020)

<em>Soap Box</em> Reprioritizing Avian Conservation Efforts
by: Travis L. DeVault
Published: (2017-02-01)

<em>Wildlife Damage Management: Prevention, Problem Solving and Conflict Resolution</em>
by: Travis L. DeVault
Published: (2017-02-01)

The New York Times' Coverage of the North American Free Trade Agreement: A Question of Balance
by: DeVault, Kimberly J.
Published: (1992)

Active and restorative campus: designing a garden street for student’s mental and physical well-being
by: DeVault, J. Ross
Published: (2015)

spritian_news_149

The Clinical Application of Neoantigens in Esophageal Cancer
by: Yi-Min Gu, et al.
Published: (2021-07-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
by: Wang Wanqiu
Published: (2019-01-01)

Neoantigen vaccine: an emerging tumor immunotherapy
by: Miao Peng, et al.
Published: (2019-08-01)

The Ways of Isolating Neoantigen-Specific T Cells
by: Qing Li, et al.
Published: (2020-08-01)

Structure Based Prediction of Neoantigen Immunogenicity
by: Timothy P. Riley, et al.
Published: (2019-08-01)

Progress in Neoantigen Targeted Cancer Immunotherapies
by: Xue-Jiao Han, et al.
Published: (2020-07-01)

Mutation-Derived Neoantigens for Cancer Immunotherapy
by: John C. Castle, et al.
Published: (2019-08-01)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
by: Lijin Li, et al.
Published: (2021-04-01)

Hedge fund politics and portfolios
by: DeVault, Luke, et al.
Published: (2017)

Protein citrullination as a source of cancer neoantigens
by: Makoto Kobayashi, et al.
Published: (2021-06-01)

Neoantigens elicit T cell responses in breast cancer
by: Takafumi Morisaki, et al.
Published: (2021-06-01)

Computational Prediction and Validation of Tumor-Associated Neoantigens
by: Vladimir Roudko, et al.
Published: (2020-01-01)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
by: Malte Roerden, et al.
Published: (2019-12-01)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
by: Yugang Guo, et al.
Published: (2018-07-01)

The role of neoantigen in immune checkpoint blockade therapy
by: Ming Yi, et al.
Published: (2018-11-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
by: Zheying Zhang, et al.
Published: (2021-04-01)

Development of cancer nanovaccines based on glyco-neoantigens
by: Beatriz Gusmão Frango Teixeira
Published: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2drkls3ettd78b320fp5tahp0